2 news items
BeyondSpring To Host Virtual R&D Day to Discuss New Plinabulin Development Strategy for Cancer and Updates for SEED Therapeutics
BYSI
3 May 24
will discuss below topics: Plinabulin history and development strategy for cancerPlinabulin's immunomodulatory activity
BeyondSpring Announces First Patient Dosed with Pembrolizumab, Plinabulin Plus Etoposide/Platinum in a Phase 2 Investigator-initiated Study of First-Line Extensive-Stage Small-Cell Lung Cancer
BYSI
25 Mar 24
is to discover innovative treatment strategies that prolong their lives," added Dr. Lan Huang, Co-Founder, Chairman and CEO at BeyondSpring
- Prev
- 1
- Next